Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2026-05-18 @ 1:44 AM
Study NCT ID:
NCT02736266
Status:
COMPLETED
Last Update Posted:
2023-07-18
First Post:
2016-04-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Pembrolizumab for Muscle-invasive Urothelial Bladder Carcinoma
Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
INT 101/16
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |